Cellular changes in Nevus associated Melanoma

Recruiting

• Conditions: C43.9; Malignant melanoma of skin, unspecified

• Registration Number: DRKS00030883
• Lead Sponsor: Charité-Universitätsmedizin Berlin, Klinik für Dermatologie, Venerologie und Allergologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-12-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

suspected (premalignant) nevus associated Melanoma
- dated and signed informed consent form

Exclusion Criteria

- patient wish
- immunocompromised patients
- participation in another study

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Characterization of molecular changes of tumor cells at the transition between benign melanocytic nevi and malignant melanoma.

Secondary Outcome Measures

Name	Time	Method
Characterization of molecular changes of cells of the tumor microenviromnet at the transition between benign melanocytic nevi and malignant melanoma.